Jing Li, PhD, Robert Tyler Braun, PhD, Sophia Kakarala, and Holly G. Prigerson, PhD
For dying patients and their loved ones to make informed decisions, physicians must share adequate information about prognoses, prospective benefits and harms of specific interventions, and costs.
AMA J Ethics. 2022;24(11):E1040-1048. doi:
10.1001/amajethics.2022.1040.
Fragmentation in US health care delivery streams and shortcomings in formal quality measures mean that transparency could be more useful to policymakers and regulators than patients.
AMA J Ethics. 2022;24(11):E1075-1082. doi:
10.1001/amajethics.2022.1075.
Sarosh Nagar, Leah Z. Rand, PhD, and Aaron S. Kesselheim, MD, JD, MPH
This article analyzes differences in prescription drug pricing transparency practices among 3 Organisation of Economic Co-operation and Development member nations.
AMA J Ethics. 2022;24(11):E1083-1090. doi:
10.1001/amajethics.2022.1083.
Aislinn C. Rookwood and Mariah Abney join Ethics Talk to discuss their article, coauthored with Hannah S. Butler-Robbins, Danielle Marie Westmark, and Dr Regina Idoate: “Arts-Based Research Methods to Explore Cancer in Indigenous Communities.”
Robin N. Richardson joins Ethics Talk to discuss her article, coauthored with Megan Hildebrandt and Joy Scanlon: “Activating Empathy Through Art in Cancer Communities.”
Megan Hildebrandt, MFA, Robin N. Richardson, MA, and Joy Scanlon
The Aesthetics of Health undergraduate visual art course at the University of Texas at Austin was designed to enhance art students’ awareness of cancer’s impact.
AMA J Ethics. 2022;24(7):E590-598. doi:
10.1001/amajethics.2022.590.